COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,895 Articles (22,568 medRxiv, 8,327 bioRxiv)

Most recent first Previous |  Page 2347: Articles 23461-23470  | Next

Peptide Antidotes to SARS-CoV-2 (COVID-19)
Watson, A., Ferreira, L. M. R., Hwang, P., Xu, J., Stroud, R.
10.1101/2020.08.06.238915 — Posted: 2020-08-06
Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex
Rosario, P. A., McNaughton, B. R.
10.1101/2020.08.06.240333 — Posted: 2020-08-06
IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection
Rosa, B. A., Ahmed, M., Singh, D. K., Choreno-Parra, J. A., Cole, J., Jimenez-Alvarez, L. A., Rodriguez-Reyna, T. S., Singh, B., Golzalez, O., Carrion, R., Schlesinger, L. S., Martin, J., Zuniga, J., Mitreva, M., Khader, S. A., Kaushal, D.
10.1101/2020.08.06.239798 — Posted: 2020-08-06 Discussion: Onsite | Offsite
Persistent bacterial coinfection of a COVID-19 patient caused by a genetically adapted Pseudomonas aeruginosa chronic colonizer
Qu, J.-X., Cai, Z., Liu, Y., Duan, X., Han, S., Zhu, Y., Jiang, Z., Zhang, Y., Zhuo, C., Liu, Y., Liu, Y., Liu, L., Yang, L.
10.1101/2020.08.05.238998 — Posted: 2020-08-06
Impact of COVID-19 on the Psychological Well-Being and Turnover Intentions of Frontline Nurses in the Community: A Cross-Sectional Study in the Philippines
De los Santos, J. A. A., Labrague, L. J.
10.1101/2020.08.05.20167411 — Posted: 2020-08-06
Analysis of SIR-Network Model on COVID-19 with respect to its impact on West Bengal in India
Khatua, D., Guha, D., Kar, S., De, A., Samanta, E.
10.1101/2020.08.05.20169037 — Posted: 2020-08-06
Health systems trust in the time of Covid-19 pandemic in Bangladesh: A qualitative exploration
Joarder, T., Bin Khaled, M. N., Zaman, S.
10.1101/2020.08.05.20157768 — Posted: 2020-08-06
U.S. Field Hospitals: A Study on Public Health Emergency Response to COVID-19
Yuan, L., Sherryn, S., Hu, P., Chen, F.
10.1101/2020.08.05.20169094 — Posted: 2020-08-06
An Examination of School Reopening Strategies during the SARS-CoV-2 Pandemic
Landeros, A., Ji, X., Lange, K. L., Stutz, T. C., Xu, J., Sehl, M. E., Sinsheimer, J. S.
10.1101/2020.08.05.20169086 — Posted: 2020-08-06 Discussion: Onsite
Inflammasome activation in COVID-19 patients
Rodrigues, T. S., Sa, K. S., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Goncalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., Veras, F. P., Toller-Kawahisa, J. E., Nascimento, D. C., de Lima, M. H., Silva, C. M., Caetite, D. B., Martins, R. B., Castro, I. A., Pontelli, M. C., de Barros, F. C., do Amaral, N. B., Giannini, M. C., Bonjorno, L. P., Lopes, M. I. F., Benatti, M. N., Santana, R. C., Vilar, F. C., Auxiliadora-Martins, M., Luppino-Assad, R., de Almeida, S. C., de Oliveira, F. R., Batah, S. S., Siyuan, L., Benatti, M. N., Cunha, T. M., Alves-Filho, J. C., Cunha
10.1101/2020.08.05.20168872 — Posted: 2020-08-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).